• Canadian Imperial Venture Corp. (CQV.H) says Ikänik Farms Inc.’s wholly owned, Colombian subsidiary Pideka SAS, has completed the first commercial sale and exportation of THC to Mexico for use in Formula Magistral
  • Ikänik was successfully able to obtain all certifications and permissions needed to legalize the process
  • Ikänik will provide cannabinoid solutions through formula magistral in LATAM to treat epilepsy, cancer, pain, nausea, anxiety, insomnia and support the growing demand of the EU marketplace
  • President of Ikänik Farms, Borja Sanz de Madrid said the company would like to thank both governments for their roles.
  • Canadian Imperial Venture Corp. opened at C$0.28 per share

Ikänik Farms’ Colombian subsidiary Pideka SAS, has completed the first commercial sale and exportation of THC to Mexico for use in Formula Magistral.

President of Ikänik Farms, International, Borja Sanz de Madrid said the company would like to thank both governments for their roles.

“We are excited to participate in this groundbreaking moment for the cannabis industry and the countries of Mexico and Colombia, as the first Colombian company to export psychoactive cannabis oil to Mexico.”

Working hand in hand with both governments, Ikänik was successfully able to obtain all certifications and permissions needed to legalize the process and complete its 15 step procedure required to export psychoactive cannabis products from Colombia to Mexico.

Ikänik Farms legalized the exportation process of psychoactive cannabis in Colombia, making it the first company to successfully complete a “commercial sale” for export.

Looking ahead, Ikänik will provide cannabinoid solutions through formula magistral in LATAM to treat epilepsy, cancer, pain, nausea, anxiety, insomnia and support the growing demand of the EU marketplace.

“We are proud to have participated in this historic moment and look forward to our growth servicing the global cannabis market,” said Brian Baca, CEO of Ikänik Farms.

Through development of its Colombian operations, Ikänik aims to support global pharmaceutical demand for a variety of cannabis products. Ikänik’s leadership brings decades of expertise in R&D, cultivation, retail, branding, and corporate finance with the ambition to build the most iconic “seed-to-sale”, “MNO” Multi-National Operator. Ikänik Farms’ operations are currently located in Colombia and California.

Canadian Imperial Venture Corp. opened at C$0.28 per share.

More From The Market Online
Cannabis Report text across cannabis leaves.

StockTalk | Cannabis Report: The Holiday Edition

MediPharm Labs has signed a share purchase agreement with Kensana Health for the purchase and sale of its facility in Napanee, Ontario.
Cannabis Report in text over top a photo of cannabis leaves

StockTalk | Cannabis Report: A new Canadian cannabis king crowned

Several TSX healthcare stocks that cater to various aspects of the healthcare market are listed on the TSX, including notable cannabis stocks
Man in cannabis field

Cannabis-based autism drug shines in phase-1 testing

Charlotte's Web (TSX:CWEB) announces positive results from a phase-1 dose trial of AJA001, its cannabis-based autism treatment.
File image of a snow drift

Buzz on the Bullboards: Feeling holiday blues, or celebrating blue chip stocks?

Some shareholders have enjoyed early holiday gifts in the form of rising stock prices, while others have faced disappointments.